Experts want two new Ebola vaccines tested in Congo

Experts want two new Ebola vaccines tested in Congo
Ebola virus Source: Photo Credit: Dr. Frederick Murphy Content Providers(s): CDC/ Dr. Frederick A. Murphy (PD / Wikimedia Commons)

The World Health Organization (WHO) is the part of the United Nations that works on health around the world. On November 4, it said that a group of experts wants to test two new vaccines against Ebola. The experts want to add the vaccines to a study that is already running in the Democratic Republic of the Congo, a large country in the middle of Africa.

Experts want two new Ebola vaccines tested in Congo
Ebola virus Source: Photo Credit: Dr. Frederick Murphy Content Providers(s): CDC/ Dr. Frederick A. Murphy (PD / Wikimedia Commons)

Ebola is spreading in that country now. This outbreak is caused by a kind of Ebola virus called the Bundibugyo strain.

The two new vaccines are ChAdOx1 and mRNA-1469. ChAdOx1 was made by the University of Oxford in England together with the Serum Institute of India. mRNA-1469 was made by the company Moderna. Both vaccines were designed just for the Bundibugyo strain. This is the first time such a vaccine will be tested during an outbreak. The two vaccines will join the study after they get official permission from the countries.

The study is called the Tumaini trial. It uses a method called ring vaccination. When a person is confirmed to have Ebola, the people who had contact with that person get the vaccine. This group of people is called a ring. Four rings are already running, and more are being prepared. The trial can test several vaccines at the same time. The first vaccine in the trial is Ervebo. Ervebo already exists, but it was made for a different kind of Ebola, the Zaire strain. The trial is checking how well it works against the Bundibugyo strain.

Doctors are also testing medicines for people who are already sick. This study is called the PARTNERS trial, and it started in July. It is testing a medicine called MBP134, a medicine called remdesivir, and the two medicines together. Another medicine, maftivimab, will be added soon. A different study is looking at obeldesivir. This medicine may stop people from getting sick after they have been near the virus.

The first results from the medicine trial are expected within a few months. Results from the vaccine trial are expected in early 2027. Tedros Adhanom Ghebreyesus, the head of the WHO, said, "Vaccines alone will not end this outbreak, but they can be a powerful new tool."

Glossary

  • 369 words
  • 29 sentences
  • 4 mins to read